<DOC>
	<DOCNO>NCT01177514</DOCNO>
	<brief_summary>The primary aim study determine treatment Gabapentin take systemically ( oral tablet ) patient photorefractive keratectomy ( PRK ) surgical treatment reduce post surgical neuropathic pain discomfort . The investigator main Hypothesis gabapentin give prior refractive surgery prevent central sensitization local allodynia .</brief_summary>
	<brief_title>The Role Gabapentin Postoperative Pain Epithelialization After Photorefractive Keratectomy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Subjects must least 18 year age 2 . Subjects must corneal disease degeneration 3 . Subjects must candidate LASIK PRK refractive surgery 1 . History topical ocular medication within 4 week prior enrollment 2 . History conjunctivitis ocular inflammation within 4 week prior enrollment 3 . History previous refractive surgery 4 . History previous diagnosis corneal disease , degeneration , glaucoma 5 . History autoimmune disease 6 . History oral antihistamine currently within 1 week study enrollment 7 . History systemic antiinflammatory pain medication currently within 4 week study enrollment 8 . Use oral diuretic betablocker currently within 1 week study enrollment 9 . Current diagnosis dry eye 10 . Patients whose Best correct vision le 20/20 11 . Patients whose target post operative refraction plano 12 . Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Refractive surgery</keyword>
	<keyword>PRK</keyword>
	<keyword>PAIN</keyword>
	<keyword>Gabapentin</keyword>
</DOC>